Financials
Intuitive Surgical (ISRG) Financial Statements: Income, Balance Sheet & Cash Flow
Revenue, profitability, balance-sheet strength, and cash generation for ISRG. SEC filings, statements through Jun 30, 2026.
Section freshness
Prices as of Sep 18, 4:00 PM EDT · Fundamentals checked Sep 20, 8:07 AM EDT
Balance sheet coverage
ISRG balance sheet summary
Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.
0 quarterly · 4 annual rows
Latest period
ANNUAL FY2025
0 quarterly · 4 annual rows
Assets / liabilities
$20.46B
Liabilities $2.52B
Cash / debt
$3.37B
Net cash —
Equity / working capital
$17.82B
Working capital $7.77B
Financial statements
ISRG statement coverage.
Income statement, balance sheet, and cash-flow figures for ISRG, with quarterly and annual history in the tables below.
Data last updated
Jun 29, 2026
Income periods
4
Balance-sheet periods
4
Cash-flow periods
4
Quarterly and annual ISRG statements, sourced from SEC filings, statements through Jun 30, 2026.
Financial statement period
ISRG statement history
SEC filings, statements through Jun 30, 2026 · Data last updated: Jun 29, 2026
Income statement
Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.
| Period | Revenue | Gross profit | Operating income | Net income | Net margin | Revenue YoY | Net income YoY |
|---|---|---|---|---|---|---|---|
| FY2025 | $10.06B | $6.64B | $2.95B | $2.86B | 28.38% | +20.5% | +23.0% |
| FY2024 | $8.35B | $5.63B | $2.35B | $2.32B | 27.81% | +17.2% | +29.2% |
| FY2023 | $7.12B | $4.73B | $1.77B | $1.80B | 25.24% | +14.5% | +36.0% |
| FY2022 | $6.22B | $4.20B | $1.58B | $1.32B | 21.25% |
Balance sheet
Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.
| Period | Cash | Current assets | Current liabilities | Total assets | Total liabilities | Total equity |
|---|---|---|---|---|---|---|
| FY2025 | $3.37B | $9.78B | $2.01B | $20.46B | $2.52B | $17.82B |
| FY2024 | $2.03B | $7.11B | $1.75B | $18.74B | $2.21B | $16.43B |
| FY2023 | $2.75B | $7.89B | $1.66B | $15.44B | $2.04B | $13.31B |
| FY2022 | $1.58B | $6.25B | $1.42B | $12.97B | $1.86B | $11.04B |
Cash flow
Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.
| Period | Operating cash flow | Net income | Buybacks |
|---|---|---|---|
| FY2025 | $3.03B | $2.86B | $2.30B |
| FY2024 | $2.42B | $2.32B | — |
| FY2023 | $1.81B | $1.80B | $416.30M |
| FY2022 | $1.49B | $1.32B | $2.61B |
Valuation and returns
- Enterprise value
- $138.16B
- TECHi computed
Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.
Annual revenue and income multiples
Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.
- Annual revenue base
- $10.06B
- Annual statement 2025-12-31
- Annual income base
- $2.86B
- Annual statement 2025-12-31
- Market cap / annual revenue
- 14.00
- Live market value divided by annual revenue
- Market cap / annual income
- 49.34
- Live market value divided by annual net income
Annual sales and income multiple
Market capitalization bridge
TTM valuation multiples
- TTM revenue
- $11.03B
- Trailing twelve months
- EBIT fallback
- $2.95B
- Annual operating income fallback
- Market cap / TTM revenue
- 12.77
- Live market value divided by trailing twelve months revenue
- EV / TTM revenue
- 12.52
- Enterprise value divided by trailing twelve months revenue
Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.
Profit multiples
Efficiency
- Revenue / employee
- $648,281.535
- 17,021 employees
- Market cap / employee
- $8.28M
- Live value per employee
Balance sheet · ANNUAL FY2025
- Cash & equivalents
- $3.37B
- Total equity
- $17.82B
Balance sheet detail
- Current assets
- $9.78B
- Current liabilities
- $2.01B
- Inventory
- $1.84B
- Receivables
- $1.53B
- Property, plant & equipment
- $5.34B
Debt and liquidity
Cash + short-term investments + receivables / current liabilities
Shareholder return
Cash generation
- Operating cash flow
- $3.03B
- Capital returned
- $2.30B
- Buybacks + dividends paid
Cash-flow detail
- Investing cash flow
- $665.80M
- Financing cash flow
- -$2.36B
- Buybacks
- $2.30B
- Net buybacks
- $2.30B
- Repurchases less stock issuance
Frequently asked
Common questions.
What financial data is available for ISRG?
TECHi shows Intuitive Surgical's income statement, balance sheet, and cash-flow statement by reported period, with each figure attributed to its source. Line items the company does not report are left blank rather than estimated.
How current are ISRG's financial statements?
Each ISRG statement is labelled with its reported period and source, so you can see exactly which quarter or fiscal year a figure covers and when the data was last updated.